Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucilla Nobbio

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|August 10, 2004
Does parkin play a role in the peripheral nervous system? A family reportGiovanni Abbruzzese, Simona Pigullo, Angelo Schenone, et al.
International Journal of Molecular Sciences|April 17, 2025
Basic Pathological Mechanisms in Peripheral Nerve DiseasesAngelo Schenone, Sara Massucco, Cristina Schenone, et al.
Molecular and Cellular Neurosciences|March 31, 2005
Experimental Charcot-Marie-Tooth type 1A: a cDNA microarrays analysisTiziana Vigo, Lucilla Nobbio, Paul Van Hummelen, et al.
The Journal of Biological Chemistry|May 5, 2010
Diadenosine homodinucleotide products of ADP-ribosyl cyclases behave as modulators of the purinergic receptor P2X7Santina Bruzzone, Giovanna Basile, Madhu Parakkottil Chothi, et al.
Experimental Neurology|October 12, 2004
Early abnormalities in sciatic nerve function and structure in a rat model of Charcot-Marie-Tooth type 1A diseaseMarina Grandis, Massimo Leandri, Tiziana Vigo, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|March 20, 2010
The spectrum of GNE mutations: allelic heterogeneity for a common phenotypeMarina Grandis, Rossella Gulli, Denise Cassandrini, et al.
Human Molecular Genetics|March 14, 2008
Different cellular and molecular mechanisms for early and late-onset myelin protein zero mutationsMarina Grandis, Tiziana Vigo, Mario Passalacqua, et al.
Scientific Reports|August 12, 2017
Sphingomyelin as a myelin biomarker in CSF of acquired demyelinating neuropathiesGiovanna Capodivento, Davide Visigalli, Martina Garnero, et al.
Human Molecular Genetics|July 31, 2022
A novel mouse model of CMT1B identifies hyperglycosylation as a new pathogenetic mechanismFrancesca A Veneri, Valeria Prada, Rosa Mastrangelo, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 24, 2024
Tezacaftor is a direct inhibitor of sphingolipid delta-4 desaturase enzyme (DEGS)Dinu Zinovie Ciobanu, Nara Liessi, Valeria Tomati, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Movement Disorders : Official Journal of the Movement Disorder Society|August 10, 2004
Does parkin play a role in the peripheral nervous system? A family reportGiovanni Abbruzzese, Simona Pigullo, Angelo Schenone, et al.
International Journal of Molecular Sciences|April 17, 2025
Basic Pathological Mechanisms in Peripheral Nerve DiseasesAngelo Schenone, Sara Massucco, Cristina Schenone, et al.
Molecular and Cellular Neurosciences|March 31, 2005
Experimental Charcot-Marie-Tooth type 1A: a cDNA microarrays analysisTiziana Vigo, Lucilla Nobbio, Paul Van Hummelen, et al.
The Journal of Biological Chemistry|May 5, 2010
Diadenosine homodinucleotide products of ADP-ribosyl cyclases behave as modulators of the purinergic receptor P2X7Santina Bruzzone, Giovanna Basile, Madhu Parakkottil Chothi, et al.
Experimental Neurology|October 12, 2004
Early abnormalities in sciatic nerve function and structure in a rat model of Charcot-Marie-Tooth type 1A diseaseMarina Grandis, Massimo Leandri, Tiziana Vigo, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|March 20, 2010
The spectrum of GNE mutations: allelic heterogeneity for a common phenotypeMarina Grandis, Rossella Gulli, Denise Cassandrini, et al.
Human Molecular Genetics|March 14, 2008
Different cellular and molecular mechanisms for early and late-onset myelin protein zero mutationsMarina Grandis, Tiziana Vigo, Mario Passalacqua, et al.
Scientific Reports|August 12, 2017
Sphingomyelin as a myelin biomarker in CSF of acquired demyelinating neuropathiesGiovanna Capodivento, Davide Visigalli, Martina Garnero, et al.
Human Molecular Genetics|July 31, 2022
A novel mouse model of CMT1B identifies hyperglycosylation as a new pathogenetic mechanismFrancesca A Veneri, Valeria Prada, Rosa Mastrangelo, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 24, 2024
Tezacaftor is a direct inhibitor of sphingolipid delta-4 desaturase enzyme (DEGS)Dinu Zinovie Ciobanu, Nara Liessi, Valeria Tomati, et al.
Pageof 4